4.6 Article

Targeted delivery of vitamin D to the colon using β-glucuronides of vitamin D: therapeutic effects in a murine model of inflammatory bowel disease

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpgi.00156.2011

Keywords

1,25-dihydroxyvitamin D-3; 1,25-dihydroxyvitamin D-3-25-beta-glucuronide; 24-hydroxylase; dextran sodium sulfate

Funding

  1. Grow Iowa Values Fund

Ask authors/readers for more resources

Goff JP, Koszewski NJ, Haynes JS, Horst RL. Targeted delivery of vitamin D to the colon using beta-glucuronides of vitamin D: therapeutic effects in a murine model of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 302: G460-G469, 2012. First published November 23, 2011; doi:10.1152/ajpgi.00156.2011.-1,25-Dihydroxyvitamin D-3 [1,25(OH)(2)D] has been shown to inhibit development of dextran sodium sulfate (DSS)-induced colitis in mice but can also cause hypercalcemia. The aim of this study was to evaluate whether beta-glucuronides of vitamin D could deliver 1,25(OH)(2)D to the colon to ameliorate colitis while reducing the risk of hypercalcemia. Initial studies demonstrated that bacteria residing in the lower intestinal tract were capable of liberating 1,25(OH)(2)D from 1,25-dihydroxyvitamin D-3-25-beta-glucuronide [beta-gluc-1,25(OH)(2)D]. We also determined that a much greater upregulation of the vitamin D-dependent 24-hydroxylase gene (Cyp24) was induced in the colon by treatment of mice with an oral dose of beta-gluc-1,25(OH)(2)D than 1,25(OH) 2D, demonstrating targeted delivery of 1,25(OH)(2)D to the colon. We then tested beta-glucuronides of vitamin D in the mouse DSS colitis model in two studies. In mice receiving DSS dissolved in distilled water and treated with 1,25(OH)(2)D or beta-gluc-1,25(OH)(2)D, severity of colitis was reduced. Combination of beta-gluc-1,25(OH)(2)D with 25-hydroxyvitamin D-3-25-beta-glucuronide [beta-gluc-25(OH)D] resulted in the greatest reduction of colitis lesions and symptoms in DSS-treated mice. Plasma calcium concentrations were lower in mice treated with beta-gluc-1,25(OH)(2)D alone or in combination with beta-gluc25(OH)D than in mice treated with 1,25(OH)(2)D, which were hypercalcemic at the time of death. beta-Glucuronides of vitamin D compounds can deliver 1,25(OH)(2)D to the lower intestine and can reduce symptoms and lesions of acute colitis in this model.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available